ClinicalTrials.Veeva

Menu
D

Deep Blue Retina Clinical Research | Southaven, MS

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

UBX1325
BI 764524
Foselutoclax

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join...

Enrolling
Diabetic Retinopathy
Drug: BI 764524
Drug: Aflibercept (Eylea®) - US only

The goal of this clinical trial is to assess the efficacy and safety of multiple doses of foselutoclax (UBX1325) in patients with Diabetic Macular Ed...

Active, not recruiting
Edema
Diabetic Macular Edema
Drug: foselutoclax
Drug: Aflibercept

Trial sponsors

Boehringer Ingelheim logo
Genentech logo
N
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems